nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP4A11—Cisplatin—germ cell cancer	0.176	0.238	CbGbCtD
Lansoprazole—CYP2C18—Ifosfamide—germ cell cancer	0.159	0.214	CbGbCtD
Lansoprazole—ABCG2—Dactinomycin—germ cell cancer	0.0604	0.0817	CbGbCtD
Lansoprazole—CYP2C8—Ifosfamide—germ cell cancer	0.038	0.0514	CbGbCtD
Lansoprazole—ABCG2—Cisplatin—germ cell cancer	0.0347	0.0469	CbGbCtD
Lansoprazole—ABCG2—Etoposide—germ cell cancer	0.0341	0.0461	CbGbCtD
Lansoprazole—CYP2C19—Ifosfamide—germ cell cancer	0.0319	0.0431	CbGbCtD
Lansoprazole—CYP2C9—Ifosfamide—germ cell cancer	0.0265	0.0358	CbGbCtD
Lansoprazole—ABCG2—Methotrexate—germ cell cancer	0.0225	0.0305	CbGbCtD
Lansoprazole—ABCB1—Dactinomycin—germ cell cancer	0.0218	0.0295	CbGbCtD
Lansoprazole—CYP2C8—Etoposide—germ cell cancer	0.0182	0.0246	CbGbCtD
Lansoprazole—CYP3A4—Ifosfamide—germ cell cancer	0.0154	0.0208	CbGbCtD
Lansoprazole—CYP1A2—Etoposide—germ cell cancer	0.0141	0.019	CbGbCtD
Lansoprazole—ABCB1—Vinblastine—germ cell cancer	0.0137	0.0184	CbGbCtD
Lansoprazole—CYP2C9—Cisplatin—germ cell cancer	0.0129	0.0174	CbGbCtD
Lansoprazole—CYP2D6—Vinblastine—germ cell cancer	0.0129	0.0174	CbGbCtD
Lansoprazole—ABCB1—Cisplatin—germ cell cancer	0.0125	0.0169	CbGbCtD
Lansoprazole—ABCB1—Etoposide—germ cell cancer	0.0123	0.0166	CbGbCtD
Lansoprazole—CYP3A4—Vinblastine—germ cell cancer	0.00818	0.0111	CbGbCtD
Lansoprazole—ABCB1—Methotrexate—germ cell cancer	0.00813	0.011	CbGbCtD
Lansoprazole—CYP3A4—Etoposide—germ cell cancer	0.00737	0.00996	CbGbCtD
Lansoprazole—CYP2C9—cardial valve—germ cell cancer	0.00659	0.106	CbGeAlD
Lansoprazole—MAPT—trigeminal ganglion—germ cell cancer	0.00237	0.0381	CbGeAlD
Lansoprazole—ATP4A—neck—germ cell cancer	0.00203	0.0327	CbGeAlD
Lansoprazole—MAPT—retina—germ cell cancer	0.00202	0.0325	CbGeAlD
Lansoprazole—ATP4B—endocrine gland—germ cell cancer	0.002	0.0322	CbGeAlD
Lansoprazole—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00187	0.12	CbGpPWpGaD
Lansoprazole—MAPT—telencephalon—germ cell cancer	0.00186	0.0299	CbGeAlD
Lansoprazole—CYP2C19—urine—germ cell cancer	0.00183	0.0295	CbGeAlD
Lansoprazole—MAPT—pituitary gland—germ cell cancer	0.00151	0.0243	CbGeAlD
Lansoprazole—CYP1A2—urine—germ cell cancer	0.0015	0.0241	CbGeAlD
Lansoprazole—MAPT—medulla oblongata—germ cell cancer	0.00146	0.0235	CbGeAlD
Lansoprazole—CYP2C9—urine—germ cell cancer	0.00142	0.0229	CbGeAlD
Lansoprazole—MAPT—adrenal gland—germ cell cancer	0.00135	0.0217	CbGeAlD
Lansoprazole—MAPT—midbrain—germ cell cancer	0.00133	0.0215	CbGeAlD
Lansoprazole—MAPT—spinal cord—germ cell cancer	0.0013	0.0209	CbGeAlD
Lansoprazole—CYP1A1—skin epidermis—germ cell cancer	0.0012	0.0192	CbGeAlD
Lansoprazole—MAPT—testis—germ cell cancer	0.00112	0.018	CbGeAlD
Lansoprazole—CYP3A4—urine—germ cell cancer	0.00108	0.0174	CbGeAlD
Lansoprazole—CYP4A11—endocrine gland—germ cell cancer	0.00108	0.0174	CbGeAlD
Lansoprazole—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00107	0.0688	CbGpPWpGaD
Lansoprazole—CYP2D6—urine—germ cell cancer	0.00107	0.0172	CbGeAlD
Lansoprazole—MAPT—cerebellum—germ cell cancer	0.00103	0.0166	CbGeAlD
Lansoprazole—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00101	0.0647	CbGpPWpGaD
Lansoprazole—ATP4A—adrenal gland—germ cell cancer	0.001	0.0161	CbGeAlD
Lansoprazole—ATP4A—endocrine gland—germ cell cancer	0.00087	0.014	CbGeAlD
Lansoprazole—ATP4B—Ion channel transport—SCNN1A—germ cell cancer	0.000862	0.0553	CbGpPWpGaD
Lansoprazole—ATP4A—head—germ cell cancer	0.000859	0.0138	CbGeAlD
Lansoprazole—MAPT—brain—germ cell cancer	0.000838	0.0135	CbGeAlD
Lansoprazole—ATP4A—testis—germ cell cancer	0.00083	0.0133	CbGeAlD
Lansoprazole—MAPT—lymph node—germ cell cancer	0.00081	0.013	CbGeAlD
Lansoprazole—ATP4A—Ion channel transport—SCNN1A—germ cell cancer	0.000768	0.0493	CbGpPWpGaD
Lansoprazole—ATP4A—cerebellum—germ cell cancer	0.000766	0.0123	CbGeAlD
Lansoprazole—CYP2C18—endocrine gland—germ cell cancer	0.000715	0.0115	CbGeAlD
Lansoprazole—ATP4A—brain—germ cell cancer	0.000622	0.01	CbGeAlD
Lansoprazole—CYP2C18—Metapathway biotransformation—NAT9—germ cell cancer	0.000605	0.0388	CbGpPWpGaD
Lansoprazole—CYP1B1—eye—germ cell cancer	0.000602	0.00969	CbGeAlD
Lansoprazole—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00058	0.0372	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000577	0.037	CbGpPWpGaD
Lansoprazole—CYP1B1—telencephalon—germ cell cancer	0.000549	0.00884	CbGeAlD
Lansoprazole—CYP1B1—skin of body—germ cell cancer	0.000524	0.00843	CbGeAlD
Lansoprazole—ABCG2—trigeminal ganglion—germ cell cancer	0.000521	0.00838	CbGeAlD
Lansoprazole—CYP1B1—decidua—germ cell cancer	0.00052	0.00837	CbGeAlD
Lansoprazole—CYP1B1—gonad—germ cell cancer	0.000458	0.00737	CbGeAlD
Lansoprazole—CYP1B1—uterus—germ cell cancer	0.000455	0.00733	CbGeAlD
Lansoprazole—CYP1B1—pituitary gland—germ cell cancer	0.000447	0.00719	CbGeAlD
Lansoprazole—CYP1B1—Metapathway biotransformation—NAT9—germ cell cancer	0.000446	0.0286	CbGpPWpGaD
Lansoprazole—ABCB1—blood vessel—germ cell cancer	0.000416	0.00669	CbGeAlD
Lansoprazole—ABCG2—telencephalon—germ cell cancer	0.000409	0.00658	CbGeAlD
Lansoprazole—CYP1B1—adrenal gland—germ cell cancer	0.000399	0.00643	CbGeAlD
Lansoprazole—ABCG2—decidua—germ cell cancer	0.000387	0.00624	CbGeAlD
Lansoprazole—CYP1B1—female gonad—germ cell cancer	0.000372	0.00599	CbGeAlD
Lansoprazole—CYP1A1—skin of body—germ cell cancer	0.00037	0.00596	CbGeAlD
Lansoprazole—MAPT—Kit receptor signaling pathway—KITLG—germ cell cancer	0.000366	0.0235	CbGpPWpGaD
Lansoprazole—CYP1B1—endocrine gland—germ cell cancer	0.000346	0.00557	CbGeAlD
Lansoprazole—CYP2C8—pituitary gland—germ cell cancer	0.000342	0.00551	CbGeAlD
Lansoprazole—CYP1B1—head—germ cell cancer	0.000342	0.0055	CbGeAlD
Lansoprazole—ABCG2—uterus—germ cell cancer	0.000339	0.00545	CbGeAlD
Lansoprazole—ABCG2—pituitary gland—germ cell cancer	0.000333	0.00536	CbGeAlD
Lansoprazole—CYP1B1—testis—germ cell cancer	0.00033	0.00531	CbGeAlD
Lansoprazole—CYP1A1—uterus—germ cell cancer	0.000322	0.00518	CbGeAlD
Lansoprazole—ABCG2—medulla oblongata—germ cell cancer	0.000321	0.00517	CbGeAlD
Lansoprazole—CYP2D6—brainstem—germ cell cancer	0.000316	0.00508	CbGeAlD
Lansoprazole—CYP1B1—cerebellum—germ cell cancer	0.000305	0.00491	CbGeAlD
Lansoprazole—CYP2C19—endocrine gland—germ cell cancer	0.000304	0.00489	CbGeAlD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.0003	0.0192	CbGpPWpGaD
Lansoprazole—ABCG2—adrenal gland—germ cell cancer	0.000297	0.00479	CbGeAlD
Lansoprazole—ABCG2—midbrain—germ cell cancer	0.000294	0.00472	CbGeAlD
Lansoprazole—MAPT—BDNF signaling pathway—ALPL—germ cell cancer	0.000288	0.0185	CbGpPWpGaD
Lansoprazole—ABCG2—bone marrow—germ cell cancer	0.000288	0.00463	CbGeAlD
Lansoprazole—ABCG2—spinal cord—germ cell cancer	0.000286	0.00461	CbGeAlD
Lansoprazole—CYP2D6—telencephalon—germ cell cancer	0.00028	0.00451	CbGeAlD
Lansoprazole—ABCG2—female gonad—germ cell cancer	0.000277	0.00446	CbGeAlD
Lansoprazole—CYP1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.000275	0.0176	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000267	0.0171	CbGpPWpGaD
Lansoprazole—CYP2C8—endocrine gland—germ cell cancer	0.000265	0.00427	CbGeAlD
Lansoprazole—CYP1A1—female gonad—germ cell cancer	0.000263	0.00424	CbGeAlD
Lansoprazole—ABCB1—trigeminal ganglion—germ cell cancer	0.000257	0.00413	CbGeAlD
Lansoprazole—CYP2C8—testis—germ cell cancer	0.000253	0.00407	CbGeAlD
Lansoprazole—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000252	0.0162	CbGpPWpGaD
Lansoprazole—MAPT—Kit receptor signaling pathway—KIT—germ cell cancer	0.00025	0.016	CbGpPWpGaD
Lansoprazole—CYP1A2—endocrine gland—germ cell cancer	0.000248	0.00399	CbGeAlD
Lansoprazole—ABCB1—embryo—germ cell cancer	0.000248	0.00399	CbGeAlD
Lansoprazole—CYP1B1—brain—germ cell cancer	0.000248	0.00399	CbGeAlD
Lansoprazole—ABCG2—testis—germ cell cancer	0.000246	0.00396	CbGeAlD
Lansoprazole—CYP1A1—endocrine gland—germ cell cancer	0.000245	0.00394	CbGeAlD
Lansoprazole—CYP1A1—head—germ cell cancer	0.000242	0.00389	CbGeAlD
Lansoprazole—CYP1B1—lymph node—germ cell cancer	0.000239	0.00385	CbGeAlD
Lansoprazole—CYP2C9—endocrine gland—germ cell cancer	0.000236	0.00379	CbGeAlD
Lansoprazole—ABCG2—cerebellum—germ cell cancer	0.000227	0.00365	CbGeAlD
Lansoprazole—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	0.000225	0.0144	CbGpPWpGaD
Lansoprazole—ABCB1—retina—germ cell cancer	0.000219	0.00353	CbGeAlD
Lansoprazole—CYP4A11—NRF2 pathway—SLC2A3—germ cell cancer	0.000217	0.0139	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000207	0.0133	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000205	0.0131	CbGpPWpGaD
Lansoprazole—ABCB1—telencephalon—germ cell cancer	0.000202	0.00324	CbGeAlD
Lansoprazole—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000197	0.00108	CcSEcCtD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000196	0.0126	CbGpPWpGaD
Lansoprazole—Decreased appetite—Bleomycin—germ cell cancer	0.000196	0.00108	CcSEcCtD
Lansoprazole—Muscle spasms—Cisplatin—germ cell cancer	0.000196	0.00107	CcSEcCtD
Lansoprazole—Angiopathy—Etoposide—germ cell cancer	0.000194	0.00107	CcSEcCtD
Lansoprazole—Confusional state—Ifosfamide—germ cell cancer	0.000194	0.00107	CcSEcCtD
Lansoprazole—Immune system disorder—Etoposide—germ cell cancer	0.000194	0.00106	CcSEcCtD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000193	0.0124	CbGpPWpGaD
Lansoprazole—Mediastinal disorder—Etoposide—germ cell cancer	0.000193	0.00106	CcSEcCtD
Lansoprazole—Pain—Bleomycin—germ cell cancer	0.000193	0.00106	CcSEcCtD
Lansoprazole—Oedema—Ifosfamide—germ cell cancer	0.000193	0.00106	CcSEcCtD
Lansoprazole—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000193	0.00106	CcSEcCtD
Lansoprazole—MAPT—MAPK Signaling Pathway—FGF4—germ cell cancer	0.000193	0.0124	CbGpPWpGaD
Lansoprazole—Chills—Etoposide—germ cell cancer	0.000192	0.00106	CcSEcCtD
Lansoprazole—Vision blurred—Cisplatin—germ cell cancer	0.000192	0.00105	CcSEcCtD
Lansoprazole—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000192	0.00105	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000192	0.00105	CcSEcCtD
Lansoprazole—Asthenia—Vinblastine—germ cell cancer	0.000192	0.00105	CcSEcCtD
Lansoprazole—Infection—Ifosfamide—germ cell cancer	0.000192	0.00105	CcSEcCtD
Lansoprazole—ABCB1—decidua—germ cell cancer	0.000191	0.00307	CbGeAlD
Lansoprazole—Tremor—Cisplatin—germ cell cancer	0.000191	0.00105	CcSEcCtD
Lansoprazole—CYP2D6—female gonad—germ cell cancer	0.00019	0.00306	CbGeAlD
Lansoprazole—CYP2C8—brain—germ cell cancer	0.00019	0.00305	CbGeAlD
Lansoprazole—Alopecia—Etoposide—germ cell cancer	0.000189	0.00104	CcSEcCtD
Lansoprazole—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000189	0.00104	CcSEcCtD
Lansoprazole—Nervous system disorder—Ifosfamide—germ cell cancer	0.000189	0.00104	CcSEcCtD
Lansoprazole—Ill-defined disorder—Cisplatin—germ cell cancer	0.000189	0.00104	CcSEcCtD
Lansoprazole—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000189	0.00104	CcSEcCtD
Lansoprazole—Anaemia—Cisplatin—germ cell cancer	0.000188	0.00103	CcSEcCtD
Lansoprazole—MAPT—IL-5 Signaling Pathway—MYC—germ cell cancer	0.000187	0.012	CbGpPWpGaD
Lansoprazole—Skin disorder—Ifosfamide—germ cell cancer	0.000187	0.00103	CcSEcCtD
Lansoprazole—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000186	0.00102	CcSEcCtD
Lansoprazole—Feeling abnormal—Bleomycin—germ cell cancer	0.000186	0.00102	CcSEcCtD
Lansoprazole—Osteoarthritis—Methotrexate—germ cell cancer	0.000186	0.00102	CcSEcCtD
Lansoprazole—ABCG2—brain—germ cell cancer	0.000184	0.00297	CbGeAlD
Lansoprazole—Anorexia—Ifosfamide—germ cell cancer	0.000184	0.00101	CcSEcCtD
Lansoprazole—Malaise—Cisplatin—germ cell cancer	0.000184	0.00101	CcSEcCtD
Lansoprazole—Decreased appetite—Dactinomycin—germ cell cancer	0.000183	0.001	CcSEcCtD
Lansoprazole—Diarrhoea—Vinblastine—germ cell cancer	0.000183	0.001	CcSEcCtD
Lansoprazole—Dysgeusia—Etoposide—germ cell cancer	0.000183	0.001	CcSEcCtD
Lansoprazole—Leukopenia—Cisplatin—germ cell cancer	0.000182	0.001	CcSEcCtD
Lansoprazole—Fatigue—Dactinomycin—germ cell cancer	0.000181	0.000995	CcSEcCtD
Lansoprazole—Back pain—Etoposide—germ cell cancer	0.00018	0.00099	CcSEcCtD
Lansoprazole—MAPT—IL-2 Signaling Pathway—MYC—germ cell cancer	0.00018	0.0116	CbGpPWpGaD
Lansoprazole—Hypotension—Ifosfamide—germ cell cancer	0.00018	0.000989	CcSEcCtD
Lansoprazole—Pain—Dactinomycin—germ cell cancer	0.00018	0.000987	CcSEcCtD
Lansoprazole—CYP3A4—endocrine gland—germ cell cancer	0.00018	0.00289	CbGeAlD
Lansoprazole—Muscle spasms—Etoposide—germ cell cancer	0.000179	0.000984	CcSEcCtD
Lansoprazole—Urticaria—Bleomycin—germ cell cancer	0.000179	0.000983	CcSEcCtD
Lansoprazole—Body temperature increased—Bleomycin—germ cell cancer	0.000178	0.000979	CcSEcCtD
Lansoprazole—ABCG2—lymph node—germ cell cancer	0.000178	0.00287	CbGeAlD
Lansoprazole—MAPT—LKB1 signaling events—MYC—germ cell cancer	0.000177	0.0113	CbGpPWpGaD
Lansoprazole—CYP2D6—endocrine gland—germ cell cancer	0.000177	0.00284	CbGeAlD
Lansoprazole—Dizziness—Vinblastine—germ cell cancer	0.000177	0.000969	CcSEcCtD
Lansoprazole—Convulsion—Cisplatin—germ cell cancer	0.000176	0.000968	CcSEcCtD
Lansoprazole—Mood swings—Methotrexate—germ cell cancer	0.000176	0.000965	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000176	0.000964	CcSEcCtD
Lansoprazole—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000175	0.0112	CbGpPWpGaD
Lansoprazole—CYP1A1—brain—germ cell cancer	0.000175	0.00282	CbGeAlD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000175	0.0112	CbGpPWpGaD
Lansoprazole—CYP2D6—head—germ cell cancer	0.000175	0.00281	CbGeAlD
Lansoprazole—Myalgia—Cisplatin—germ cell cancer	0.000173	0.000951	CcSEcCtD
Lansoprazole—Feeling abnormal—Dactinomycin—germ cell cancer	0.000173	0.000951	CcSEcCtD
Lansoprazole—Paraesthesia—Ifosfamide—germ cell cancer	0.000173	0.00095	CcSEcCtD
Lansoprazole—Ill-defined disorder—Etoposide—germ cell cancer	0.000173	0.00095	CcSEcCtD
Lansoprazole—Anxiety—Cisplatin—germ cell cancer	0.000173	0.000948	CcSEcCtD
Lansoprazole—Anaemia—Etoposide—germ cell cancer	0.000172	0.000946	CcSEcCtD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000172	0.011	CbGpPWpGaD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000172	0.000945	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000172	0.000944	CcSEcCtD
Lansoprazole—Dyspnoea—Ifosfamide—germ cell cancer	0.000172	0.000943	CcSEcCtD
Lansoprazole—Somnolence—Ifosfamide—germ cell cancer	0.000171	0.000941	CcSEcCtD
Lansoprazole—Liver function test abnormal—Methotrexate—germ cell cancer	0.000171	0.00094	CcSEcCtD
Lansoprazole—Discomfort—Cisplatin—germ cell cancer	0.000171	0.00094	CcSEcCtD
Lansoprazole—Vomiting—Vinblastine—germ cell cancer	0.00017	0.000932	CcSEcCtD
Lansoprazole—CYP1A1—lymph node—germ cell cancer	0.000169	0.00272	CbGeAlD
Lansoprazole—CYP2D6—testis—germ cell cancer	0.000169	0.00271	CbGeAlD
Lansoprazole—Malaise—Etoposide—germ cell cancer	0.000168	0.000923	CcSEcCtD
Lansoprazole—ABCB1—gonad—germ cell cancer	0.000168	0.00271	CbGeAlD
Lansoprazole—Breast disorder—Methotrexate—germ cell cancer	0.000168	0.00092	CcSEcCtD
Lansoprazole—Vertigo—Etoposide—germ cell cancer	0.000168	0.00092	CcSEcCtD
Lansoprazole—Decreased appetite—Ifosfamide—germ cell cancer	0.000168	0.00092	CcSEcCtD
Lansoprazole—Headache—Vinblastine—germ cell cancer	0.000167	0.000918	CcSEcCtD
Lansoprazole—ABCB1—uterus—germ cell cancer	0.000167	0.00269	CbGeAlD
Lansoprazole—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000167	0.000917	CcSEcCtD
Lansoprazole—Leukopenia—Etoposide—germ cell cancer	0.000167	0.000916	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000166	0.000913	CcSEcCtD
Lansoprazole—Body temperature increased—Dactinomycin—germ cell cancer	0.000166	0.000913	CcSEcCtD
Lansoprazole—Abdominal pain—Dactinomycin—germ cell cancer	0.000166	0.000913	CcSEcCtD
Lansoprazole—Fatigue—Ifosfamide—germ cell cancer	0.000166	0.000912	CcSEcCtD
Lansoprazole—Anaphylactic shock—Cisplatin—germ cell cancer	0.000166	0.000912	CcSEcCtD
Lansoprazole—Oedema—Cisplatin—germ cell cancer	0.000166	0.000912	CcSEcCtD
Lansoprazole—Hypersensitivity—Bleomycin—germ cell cancer	0.000166	0.000912	CcSEcCtD
Lansoprazole—Infection—Cisplatin—germ cell cancer	0.000165	0.000906	CcSEcCtD
Lansoprazole—Constipation—Ifosfamide—germ cell cancer	0.000165	0.000905	CcSEcCtD
Lansoprazole—Pain—Ifosfamide—germ cell cancer	0.000165	0.000905	CcSEcCtD
Lansoprazole—ABCB1—pituitary gland—germ cell cancer	0.000164	0.00264	CbGeAlD
Lansoprazole—Loss of consciousness—Etoposide—germ cell cancer	0.000164	0.0009	CcSEcCtD
Lansoprazole—Nervous system disorder—Cisplatin—germ cell cancer	0.000163	0.000894	CcSEcCtD
Lansoprazole—Cough—Etoposide—germ cell cancer	0.000163	0.000893	CcSEcCtD
Lansoprazole—Thrombocytopenia—Cisplatin—germ cell cancer	0.000163	0.000893	CcSEcCtD
Lansoprazole—Tachycardia—Cisplatin—germ cell cancer	0.000162	0.00089	CcSEcCtD
Lansoprazole—Asthenia—Bleomycin—germ cell cancer	0.000162	0.000888	CcSEcCtD
Lansoprazole—Convulsion—Etoposide—germ cell cancer	0.000162	0.000887	CcSEcCtD
Lansoprazole—Skin disorder—Cisplatin—germ cell cancer	0.000161	0.000886	CcSEcCtD
Lansoprazole—Hypertension—Etoposide—germ cell cancer	0.000161	0.000884	CcSEcCtD
Lansoprazole—Hyperhidrosis—Cisplatin—germ cell cancer	0.000161	0.000882	CcSEcCtD
Lansoprazole—Asthma—Methotrexate—germ cell cancer	0.00016	0.00088	CcSEcCtD
Lansoprazole—Pruritus—Bleomycin—germ cell cancer	0.00016	0.000876	CcSEcCtD
Lansoprazole—Feeling abnormal—Ifosfamide—germ cell cancer	0.000159	0.000872	CcSEcCtD
Lansoprazole—Chest pain—Etoposide—germ cell cancer	0.000159	0.000872	CcSEcCtD
Lansoprazole—Eosinophilia—Methotrexate—germ cell cancer	0.000159	0.000871	CcSEcCtD
Lansoprazole—Nausea—Vinblastine—germ cell cancer	0.000159	0.000871	CcSEcCtD
Lansoprazole—Anorexia—Cisplatin—germ cell cancer	0.000158	0.000869	CcSEcCtD
Lansoprazole—ABCB1—medulla oblongata—germ cell cancer	0.000158	0.00255	CbGeAlD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000158	0.000866	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000158	0.000865	CcSEcCtD
Lansoprazole—Pancreatitis—Methotrexate—germ cell cancer	0.000157	0.000863	CcSEcCtD
Lansoprazole—Discomfort—Etoposide—germ cell cancer	0.000157	0.000861	CcSEcCtD
Lansoprazole—CYP2D6—cerebellum—germ cell cancer	0.000156	0.00251	CbGeAlD
Lansoprazole—Hypotension—Cisplatin—germ cell cancer	0.000155	0.000852	CcSEcCtD
Lansoprazole—Hypersensitivity—Dactinomycin—germ cell cancer	0.000155	0.000851	CcSEcCtD
Lansoprazole—Abdominal discomfort—Methotrexate—germ cell cancer	0.000154	0.000844	CcSEcCtD
Lansoprazole—Confusional state—Etoposide—germ cell cancer	0.000154	0.000843	CcSEcCtD
Lansoprazole—CYP4A11—PPAR Alpha Pathway—MYC—germ cell cancer	0.000153	0.00982	CbGpPWpGaD
Lansoprazole—Urticaria—Ifosfamide—germ cell cancer	0.000153	0.00084	CcSEcCtD
Lansoprazole—Abdominal pain—Ifosfamide—germ cell cancer	0.000152	0.000836	CcSEcCtD
Lansoprazole—Body temperature increased—Ifosfamide—germ cell cancer	0.000152	0.000836	CcSEcCtD
Lansoprazole—Pancytopenia—Methotrexate—germ cell cancer	0.000152	0.000836	CcSEcCtD
Lansoprazole—Anaphylactic shock—Etoposide—germ cell cancer	0.000152	0.000836	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000151	0.000831	CcSEcCtD
Lansoprazole—Infection—Etoposide—germ cell cancer	0.000151	0.00083	CcSEcCtD
Lansoprazole—Asthenia—Dactinomycin—germ cell cancer	0.000151	0.000828	CcSEcCtD
Lansoprazole—Dysuria—Methotrexate—germ cell cancer	0.00015	0.000823	CcSEcCtD
Lansoprazole—Neutropenia—Methotrexate—germ cell cancer	0.00015	0.000823	CcSEcCtD
Lansoprazole—Paraesthesia—Cisplatin—germ cell cancer	0.000149	0.000819	CcSEcCtD
Lansoprazole—Thrombocytopenia—Etoposide—germ cell cancer	0.000149	0.000818	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000149	0.000818	CcSEcCtD
Lansoprazole—Tachycardia—Etoposide—germ cell cancer	0.000149	0.000816	CcSEcCtD
Lansoprazole—Dyspnoea—Cisplatin—germ cell cancer	0.000148	0.000813	CcSEcCtD
Lansoprazole—Skin disorder—Etoposide—germ cell cancer	0.000148	0.000812	CcSEcCtD
Lansoprazole—Erectile dysfunction—Methotrexate—germ cell cancer	0.000148	0.000811	CcSEcCtD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000148	0.00947	CbGpPWpGaD
Lansoprazole—Hyperhidrosis—Etoposide—germ cell cancer	0.000147	0.000808	CcSEcCtD
Lansoprazole—ABCB1—adrenal gland—germ cell cancer	0.000147	0.00236	CbGeAlD
Lansoprazole—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000146	0.000803	CcSEcCtD
Lansoprazole—MAPT—LKB1 signaling events—TP53—germ cell cancer	0.000145	0.00932	CbGpPWpGaD
Lansoprazole—Anorexia—Etoposide—germ cell cancer	0.000145	0.000796	CcSEcCtD
Lansoprazole—ABCB1—midbrain—germ cell cancer	0.000145	0.00233	CbGeAlD
Lansoprazole—Decreased appetite—Cisplatin—germ cell cancer	0.000144	0.000793	CcSEcCtD
Lansoprazole—Diarrhoea—Dactinomycin—germ cell cancer	0.000144	0.00079	CcSEcCtD
Lansoprazole—Pneumonia—Methotrexate—germ cell cancer	0.000144	0.000789	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000143	0.000787	CcSEcCtD
Lansoprazole—Vomiting—Bleomycin—germ cell cancer	0.000143	0.000787	CcSEcCtD
Lansoprazole—Infestation NOS—Methotrexate—germ cell cancer	0.000143	0.000785	CcSEcCtD
Lansoprazole—Infestation—Methotrexate—germ cell cancer	0.000143	0.000785	CcSEcCtD
Lansoprazole—Hypotension—Etoposide—germ cell cancer	0.000142	0.000781	CcSEcCtD
Lansoprazole—Rash—Bleomycin—germ cell cancer	0.000142	0.000781	CcSEcCtD
Lansoprazole—Pain—Cisplatin—germ cell cancer	0.000142	0.00078	CcSEcCtD
Lansoprazole—Dermatitis—Bleomycin—germ cell cancer	0.000142	0.00078	CcSEcCtD
Lansoprazole—Hypersensitivity—Ifosfamide—germ cell cancer	0.000142	0.000779	CcSEcCtD
Lansoprazole—ABCB1—bone marrow—germ cell cancer	0.000142	0.00228	CbGeAlD
Lansoprazole—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000142	0.000778	CcSEcCtD
Lansoprazole—MAPT—IL-2 Signaling Pathway—HRAS—germ cell cancer	0.000142	0.00908	CbGpPWpGaD
Lansoprazole—ABCB1—spinal cord—germ cell cancer	0.000141	0.00227	CbGeAlD
Lansoprazole—Renal failure—Methotrexate—germ cell cancer	0.000141	0.000771	CcSEcCtD
Lansoprazole—Stomatitis—Methotrexate—germ cell cancer	0.000139	0.000765	CcSEcCtD
Lansoprazole—Conjunctivitis—Methotrexate—germ cell cancer	0.000139	0.000763	CcSEcCtD
Lansoprazole—Asthenia—Ifosfamide—germ cell cancer	0.000138	0.000759	CcSEcCtD
Lansoprazole—Sweating—Methotrexate—germ cell cancer	0.000137	0.000752	CcSEcCtD
Lansoprazole—Feeling abnormal—Cisplatin—germ cell cancer	0.000137	0.000752	CcSEcCtD
Lansoprazole—Paraesthesia—Etoposide—germ cell cancer	0.000137	0.00075	CcSEcCtD
Lansoprazole—ABCB1—female gonad—germ cell cancer	0.000137	0.0022	CbGeAlD
Lansoprazole—Pruritus—Ifosfamide—germ cell cancer	0.000136	0.000749	CcSEcCtD
Lansoprazole—Haematuria—Methotrexate—germ cell cancer	0.000136	0.000748	CcSEcCtD
Lansoprazole—Dyspnoea—Etoposide—germ cell cancer	0.000136	0.000745	CcSEcCtD
Lansoprazole—Somnolence—Etoposide—germ cell cancer	0.000135	0.000743	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000135	0.000742	CcSEcCtD
Lansoprazole—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000135	0.00867	CbGpPWpGaD
Lansoprazole—Epistaxis—Methotrexate—germ cell cancer	0.000135	0.00074	CcSEcCtD
Lansoprazole—Nausea—Bleomycin—germ cell cancer	0.000134	0.000735	CcSEcCtD
Lansoprazole—Vomiting—Dactinomycin—germ cell cancer	0.000134	0.000734	CcSEcCtD
Lansoprazole—MAPT—Notch Signaling Pathway—MYC—germ cell cancer	0.000134	0.00858	CbGpPWpGaD
Lansoprazole—Agranulocytosis—Methotrexate—germ cell cancer	0.000133	0.000732	CcSEcCtD
Lansoprazole—Rash—Dactinomycin—germ cell cancer	0.000133	0.000728	CcSEcCtD
Lansoprazole—Decreased appetite—Etoposide—germ cell cancer	0.000132	0.000726	CcSEcCtD
Lansoprazole—Diarrhoea—Ifosfamide—germ cell cancer	0.000132	0.000724	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000131	0.000721	CcSEcCtD
Lansoprazole—Body temperature increased—Cisplatin—germ cell cancer	0.000131	0.000721	CcSEcCtD
Lansoprazole—Fatigue—Etoposide—germ cell cancer	0.000131	0.00072	CcSEcCtD
Lansoprazole—Constipation—Etoposide—germ cell cancer	0.00013	0.000715	CcSEcCtD
Lansoprazole—Pain—Etoposide—germ cell cancer	0.00013	0.000715	CcSEcCtD
Lansoprazole—Hepatitis—Methotrexate—germ cell cancer	0.000128	0.000704	CcSEcCtD
Lansoprazole—Dizziness—Ifosfamide—germ cell cancer	0.000127	0.0007	CcSEcCtD
Lansoprazole—Pharyngitis—Methotrexate—germ cell cancer	0.000127	0.000699	CcSEcCtD
Lansoprazole—ABCB1—endocrine gland—germ cell cancer	0.000127	0.00205	CbGeAlD
Lansoprazole—Urinary tract disorder—Methotrexate—germ cell cancer	0.000127	0.000696	CcSEcCtD
Lansoprazole—CYP2D6—brain—germ cell cancer	0.000126	0.00204	CbGeAlD
Lansoprazole—Urethral disorder—Methotrexate—germ cell cancer	0.000126	0.000691	CcSEcCtD
Lansoprazole—ABCB1—head—germ cell cancer	0.000126	0.00202	CbGeAlD
Lansoprazole—Feeling abnormal—Etoposide—germ cell cancer	0.000125	0.000689	CcSEcCtD
Lansoprazole—Nausea—Dactinomycin—germ cell cancer	0.000125	0.000686	CcSEcCtD
Lansoprazole—MAPT—Copper homeostasis—TP53—germ cell cancer	0.000125	0.008	CbGpPWpGaD
Lansoprazole—Gastrointestinal pain—Etoposide—germ cell cancer	0.000125	0.000683	CcSEcCtD
Lansoprazole—Visual impairment—Methotrexate—germ cell cancer	0.000124	0.000679	CcSEcCtD
Lansoprazole—Vomiting—Ifosfamide—germ cell cancer	0.000123	0.000673	CcSEcCtD
Lansoprazole—Hypersensitivity—Cisplatin—germ cell cancer	0.000122	0.000672	CcSEcCtD
Lansoprazole—Rash—Ifosfamide—germ cell cancer	0.000122	0.000667	CcSEcCtD
Lansoprazole—Dermatitis—Ifosfamide—germ cell cancer	0.000121	0.000666	CcSEcCtD
Lansoprazole—Erythema multiforme—Methotrexate—germ cell cancer	0.000121	0.000666	CcSEcCtD
Lansoprazole—ABCB1—testis—germ cell cancer	0.000121	0.00195	CbGeAlD
Lansoprazole—Urticaria—Etoposide—germ cell cancer	0.000121	0.000664	CcSEcCtD
Lansoprazole—Body temperature increased—Etoposide—germ cell cancer	0.00012	0.000661	CcSEcCtD
Lansoprazole—Abdominal pain—Etoposide—germ cell cancer	0.00012	0.000661	CcSEcCtD
Lansoprazole—Eye disorder—Methotrexate—germ cell cancer	0.00012	0.000658	CcSEcCtD
Lansoprazole—Tinnitus—Methotrexate—germ cell cancer	0.00012	0.000657	CcSEcCtD
Lansoprazole—Asthenia—Cisplatin—germ cell cancer	0.000119	0.000654	CcSEcCtD
Lansoprazole—Cardiac disorder—Methotrexate—germ cell cancer	0.000119	0.000654	CcSEcCtD
Lansoprazole—Angiopathy—Methotrexate—germ cell cancer	0.000116	0.000639	CcSEcCtD
Lansoprazole—Immune system disorder—Methotrexate—germ cell cancer	0.000116	0.000636	CcSEcCtD
Lansoprazole—Mediastinal disorder—Methotrexate—germ cell cancer	0.000116	0.000635	CcSEcCtD
Lansoprazole—Chills—Methotrexate—germ cell cancer	0.000115	0.000632	CcSEcCtD
Lansoprazole—Nausea—Ifosfamide—germ cell cancer	0.000115	0.000628	CcSEcCtD
Lansoprazole—Diarrhoea—Cisplatin—germ cell cancer	0.000114	0.000624	CcSEcCtD
Lansoprazole—Alopecia—Methotrexate—germ cell cancer	0.000113	0.000623	CcSEcCtD
Lansoprazole—Mental disorder—Methotrexate—germ cell cancer	0.000112	0.000617	CcSEcCtD
Lansoprazole—Hypersensitivity—Etoposide—germ cell cancer	0.000112	0.000616	CcSEcCtD
Lansoprazole—ABCB1—cerebellum—germ cell cancer	0.000112	0.0018	CbGeAlD
Lansoprazole—Malnutrition—Methotrexate—germ cell cancer	0.000112	0.000613	CcSEcCtD
Lansoprazole—Erythema—Methotrexate—germ cell cancer	0.000112	0.000613	CcSEcCtD
Lansoprazole—Dysgeusia—Methotrexate—germ cell cancer	0.000109	0.000601	CcSEcCtD
Lansoprazole—Asthenia—Etoposide—germ cell cancer	0.000109	0.0006	CcSEcCtD
Lansoprazole—Back pain—Methotrexate—germ cell cancer	0.000108	0.000593	CcSEcCtD
Lansoprazole—MAPT—Kit receptor signaling pathway—HRAS—germ cell cancer	0.000108	0.00692	CbGpPWpGaD
Lansoprazole—Pruritus—Etoposide—germ cell cancer	0.000108	0.000591	CcSEcCtD
Lansoprazole—Vomiting—Cisplatin—germ cell cancer	0.000106	0.00058	CcSEcCtD
Lansoprazole—Vision blurred—Methotrexate—germ cell cancer	0.000105	0.000578	CcSEcCtD
Lansoprazole—Rash—Cisplatin—germ cell cancer	0.000105	0.000575	CcSEcCtD
Lansoprazole—Dermatitis—Cisplatin—germ cell cancer	0.000105	0.000575	CcSEcCtD
Lansoprazole—Diarrhoea—Etoposide—germ cell cancer	0.000104	0.000572	CcSEcCtD
Lansoprazole—Ill-defined disorder—Methotrexate—germ cell cancer	0.000104	0.000569	CcSEcCtD
Lansoprazole—Anaemia—Methotrexate—germ cell cancer	0.000103	0.000567	CcSEcCtD
Lansoprazole—MAPT—LPA receptor mediated events—HRAS—germ cell cancer	0.000101	0.00648	CbGpPWpGaD
Lansoprazole—Malaise—Methotrexate—germ cell cancer	0.000101	0.000553	CcSEcCtD
Lansoprazole—Dizziness—Etoposide—germ cell cancer	0.000101	0.000553	CcSEcCtD
Lansoprazole—Vertigo—Methotrexate—germ cell cancer	0.0001	0.000551	CcSEcCtD
Lansoprazole—Leukopenia—Methotrexate—germ cell cancer	0.0001	0.000549	CcSEcCtD
Lansoprazole—Nausea—Cisplatin—germ cell cancer	9.87e-05	0.000542	CcSEcCtD
Lansoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	9.83e-05	0.0063	CbGpPWpGaD
Lansoprazole—Cough—Methotrexate—germ cell cancer	9.75e-05	0.000535	CcSEcCtD
Lansoprazole—Convulsion—Methotrexate—germ cell cancer	9.68e-05	0.000531	CcSEcCtD
Lansoprazole—Vomiting—Etoposide—germ cell cancer	9.68e-05	0.000531	CcSEcCtD
Lansoprazole—Rash—Etoposide—germ cell cancer	9.6e-05	0.000527	CcSEcCtD
Lansoprazole—Dermatitis—Etoposide—germ cell cancer	9.59e-05	0.000526	CcSEcCtD
Lansoprazole—Headache—Etoposide—germ cell cancer	9.54e-05	0.000523	CcSEcCtD
Lansoprazole—Chest pain—Methotrexate—germ cell cancer	9.51e-05	0.000522	CcSEcCtD
Lansoprazole—Arthralgia—Methotrexate—germ cell cancer	9.51e-05	0.000522	CcSEcCtD
Lansoprazole—Myalgia—Methotrexate—germ cell cancer	9.51e-05	0.000522	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	9.45e-05	0.000519	CcSEcCtD
Lansoprazole—Discomfort—Methotrexate—germ cell cancer	9.4e-05	0.000516	CcSEcCtD
Lansoprazole—Confusional state—Methotrexate—germ cell cancer	9.2e-05	0.000505	CcSEcCtD
Lansoprazole—Anaphylactic shock—Methotrexate—germ cell cancer	9.12e-05	0.000501	CcSEcCtD
Lansoprazole—ABCB1—brain—germ cell cancer	9.1e-05	0.00146	CbGeAlD
Lansoprazole—Infection—Methotrexate—germ cell cancer	9.06e-05	0.000497	CcSEcCtD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—AVP—germ cell cancer	9.05e-05	0.0058	CbGpPWpGaD
Lansoprazole—Nausea—Etoposide—germ cell cancer	9.04e-05	0.000496	CcSEcCtD
Lansoprazole—Nervous system disorder—Methotrexate—germ cell cancer	8.94e-05	0.000491	CcSEcCtD
Lansoprazole—MAPT—Alzheimers Disease—TP53—germ cell cancer	8.93e-05	0.00573	CbGpPWpGaD
Lansoprazole—Thrombocytopenia—Methotrexate—germ cell cancer	8.93e-05	0.00049	CcSEcCtD
Lansoprazole—Skin disorder—Methotrexate—germ cell cancer	8.86e-05	0.000486	CcSEcCtD
Lansoprazole—Hyperhidrosis—Methotrexate—germ cell cancer	8.82e-05	0.000484	CcSEcCtD
Lansoprazole—ABCB1—lymph node—germ cell cancer	8.79e-05	0.00141	CbGeAlD
Lansoprazole—Anorexia—Methotrexate—germ cell cancer	8.69e-05	0.000477	CcSEcCtD
Lansoprazole—Hypotension—Methotrexate—germ cell cancer	8.52e-05	0.000468	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Methotrexate—germ cell cancer	8.31e-05	0.000456	CcSEcCtD
Lansoprazole—Insomnia—Methotrexate—germ cell cancer	8.25e-05	0.000453	CcSEcCtD
Lansoprazole—Paraesthesia—Methotrexate—germ cell cancer	8.19e-05	0.000449	CcSEcCtD
Lansoprazole—Dyspnoea—Methotrexate—germ cell cancer	8.13e-05	0.000446	CcSEcCtD
Lansoprazole—Somnolence—Methotrexate—germ cell cancer	8.11e-05	0.000445	CcSEcCtD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—AVP—germ cell cancer	8.07e-05	0.00517	CbGpPWpGaD
Lansoprazole—Dyspepsia—Methotrexate—germ cell cancer	8.03e-05	0.000441	CcSEcCtD
Lansoprazole—Decreased appetite—Methotrexate—germ cell cancer	7.93e-05	0.000435	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Methotrexate—germ cell cancer	7.87e-05	0.000432	CcSEcCtD
Lansoprazole—Fatigue—Methotrexate—germ cell cancer	7.86e-05	0.000432	CcSEcCtD
Lansoprazole—Pain—Methotrexate—germ cell cancer	7.8e-05	0.000428	CcSEcCtD
Lansoprazole—Feeling abnormal—Methotrexate—germ cell cancer	7.52e-05	0.000412	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Methotrexate—germ cell cancer	7.46e-05	0.000409	CcSEcCtD
Lansoprazole—Urticaria—Methotrexate—germ cell cancer	7.25e-05	0.000398	CcSEcCtD
Lansoprazole—Body temperature increased—Methotrexate—germ cell cancer	7.21e-05	0.000396	CcSEcCtD
Lansoprazole—Abdominal pain—Methotrexate—germ cell cancer	7.21e-05	0.000396	CcSEcCtD
Lansoprazole—Hypersensitivity—Methotrexate—germ cell cancer	6.72e-05	0.000369	CcSEcCtD
Lansoprazole—Asthenia—Methotrexate—germ cell cancer	6.54e-05	0.000359	CcSEcCtD
Lansoprazole—Pruritus—Methotrexate—germ cell cancer	6.45e-05	0.000354	CcSEcCtD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	6.25e-05	0.00401	CbGpPWpGaD
Lansoprazole—Diarrhoea—Methotrexate—germ cell cancer	6.24e-05	0.000342	CcSEcCtD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.24e-05	0.004	CbGpPWpGaD
Lansoprazole—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	6.09e-05	0.00391	CbGpPWpGaD
Lansoprazole—Dizziness—Methotrexate—germ cell cancer	6.03e-05	0.000331	CcSEcCtD
Lansoprazole—MAPT—MAPK Signaling Pathway—MYC—germ cell cancer	5.95e-05	0.00381	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.88e-05	0.00377	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	5.86e-05	0.00376	CbGpPWpGaD
Lansoprazole—Vomiting—Methotrexate—germ cell cancer	5.8e-05	0.000318	CcSEcCtD
Lansoprazole—Rash—Methotrexate—germ cell cancer	5.75e-05	0.000316	CcSEcCtD
Lansoprazole—Dermatitis—Methotrexate—germ cell cancer	5.75e-05	0.000315	CcSEcCtD
Lansoprazole—Headache—Methotrexate—germ cell cancer	5.71e-05	0.000314	CcSEcCtD
Lansoprazole—Nausea—Methotrexate—germ cell cancer	5.42e-05	0.000297	CcSEcCtD
Lansoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	5.41e-05	0.00347	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.37e-05	0.00344	CbGpPWpGaD
Lansoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	5.31e-05	0.00341	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—HRAS—germ cell cancer	5.28e-05	0.00339	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TP53—germ cell cancer	5.21e-05	0.00334	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	4.91e-05	0.00315	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TP53—germ cell cancer	4.88e-05	0.00313	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.41e-05	0.00283	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.08e-05	0.00262	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.02e-05	0.00258	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	3.85e-05	0.00247	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.79e-05	0.00243	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.37e-05	0.00216	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—SLC2A3—germ cell cancer	3.26e-05	0.00209	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—SLC22A3—germ cell cancer	3.21e-05	0.00206	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.02e-05	0.00194	CbGpPWpGaD
Lansoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	2.92e-05	0.00188	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—SLC2A3—germ cell cancer	2.85e-05	0.00183	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—SLC22A3—germ cell cancer	2.81e-05	0.0018	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CRABP1—germ cell cancer	2.62e-05	0.00168	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	2.46e-05	0.00157	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.33e-05	0.0015	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CRABP1—germ cell cancer	2.29e-05	0.00147	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.21e-05	0.00142	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.17e-05	0.00139	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.14e-05	0.00137	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—SLC2A3—germ cell cancer	2.1e-05	0.00135	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—SLC22A3—germ cell cancer	2.07e-05	0.00133	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.93e-05	0.00124	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.91e-05	0.00123	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.91e-05	0.00122	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.88e-05	0.00121	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.88e-05	0.00121	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.74e-05	0.00112	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CRABP1—germ cell cancer	1.69e-05	0.00108	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CRABP1—germ cell cancer	1.54e-05	0.000985	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.49e-05	0.000954	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC2A3—germ cell cancer	1.29e-05	0.00083	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC22A3—germ cell cancer	1.27e-05	0.000818	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.19e-05	0.000761	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.17e-05	0.00075	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC2A3—germ cell cancer	1.06e-05	0.000679	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC22A3—germ cell cancer	1.04e-05	0.000669	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CRABP1—germ cell cancer	1.04e-05	0.000666	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.03e-05	0.000663	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.02e-05	0.000653	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.02e-05	0.000653	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	9.85e-06	0.000632	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC2A3—germ cell cancer	9.74e-06	0.000625	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC2A3—germ cell cancer	9.66e-06	0.000619	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC22A3—germ cell cancer	9.59e-06	0.000615	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CRABP1—germ cell cancer	9.53e-06	0.000611	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC22A3—germ cell cancer	9.51e-06	0.00061	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CRABP1—germ cell cancer	8.5e-06	0.000545	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CRABP1—germ cell cancer	8.3e-06	0.000532	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A3—germ cell cancer	8.25e-06	0.000529	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC22A3—germ cell cancer	8.13e-06	0.000521	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.09e-06	0.000519	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CRABP1—germ cell cancer	7.82e-06	0.000502	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CRABP1—germ cell cancer	7.75e-06	0.000497	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CRABP1—germ cell cancer	6.63e-06	0.000425	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A3—germ cell cancer	6.37e-06	0.000408	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC22A3—germ cell cancer	6.27e-06	0.000402	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CRABP1—germ cell cancer	5.11e-06	0.000328	CbGpPWpGaD
